Bovine plasma contains two kininogens. One of them, HMW kininogen, has recently been characterized as a new coagulation factor, which is required for the activation of Hageman factor-mediated pathway. To elucidate the structural differences between HMW and LMW kininogens, these were fragmented with plasma kallikrein and snake venom kininogenase, and the resulting products were chemically identified. The kallikrein simultaneously released bradykinin and fragment 1·2 from HMW kininogen. Fragment 1·2 was a histidine-rich glycopeptide consisting of 110 amino acid residues, and its whole sequence and the location of the sugar moieties were established. The venom kininogenase liberated only bradykinin from LMW kininogen. Kinin (and fragment 1·2)-free proteins consisted of heavy and light chains. These chains constituted, respectively, the NH2-and COOH-terminal portions of both parent molecules and were held by a single disulfide bridge. The detailed studies on these chains indicated that the NH2-terminal portions of HMW and LMW kininogens are very similar for each other, whereas their COOH-terminal portions differ significantly. Concerning the results that HMW kininogen overcomes impaired coagulation and fibrinolysis of the kininogen deficient plasmas, and the kinin-free HMW protein has a weak corrective activity, it seems that the histidine-rich region found only in HMW kininogen may be closely related to the functions of the kininogen.